Ligand validation:4UHX

MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER

MTE is a Ligand Of Interest in 4UHX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UHX_MTE_A_3003	39%	17%	0.19	0.895	1.59	2.02	2	6	0	0	100%	1
4UHW_MTE_A_3003	59%	14%	0.164	0.948	1.65	2.19	2	6	1	0	100%	1
5EPG_MTE_A_3003	47%	12%	0.229	0.972	1.87	2.17	4	8	2	0	100%	1
2XTS_MTE_C_500	100%	18%	0.043	0.993	1.21	2.31	2	6	2	0	100%	1
3UNC_MTE_A_1335	99%	6%	0.049	0.985	1.91	3.14	5	8	0	0	100%	1
3NVW_MTE_C_1327	98%	17%	0.069	0.99	1.47	2.12	2	6	0	0	100%	1
3AMZ_MTE_B_1336	98%	15%	0.07	0.989	1.8	2.01	4	8	0	0	100%	1
3AM9_MTE_B_1333	97%	9%	0.076	0.993	1.34	3.12	4	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.